1 / 13

Problem Definition

Problem Definition. 19y/o previously healthy male with concerning social hx Subacute onset progressive fatigue, weakness, paresthesias , dysphagia , hoarse voice Exam findings of symmetric weakness and decreased DTR’s, facial weakness, NIF’s c/w respiratory compromise

maleah
Download Presentation

Problem Definition

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Problem Definition • 19y/o previously healthy male with concerning social hx • Subacute onset progressive fatigue, weakness, paresthesias, dysphagia, hoarse voice • Exam findings of symmetric weakness and decreased DTR’s, facial weakness, NIF’s c/w respiratory compromise • Also with vomiting, ulcerative gingivitis, wt loss

  2. Illness Script • Acute to subacute, rapidly progressive, symmetric ascending muscle weakness, lack of deep tendon reflexes, with prodromal viral illness.

  3. Guillian-Barre • Heterogeneous syndrome with several variant forms • Demyelinating (classic) vs. axonal • AIDP: Acute inflammatory demyelinatingpolyradiculopathy

  4. Guillian-Barre: Pathophysiology • Immune-mediated condition of peripheral nervous system • Pathogen shares similar antigenic sites as host axon or peripheral nerve myelin • Autoimmune response • Multifocal areas of inflammation, especially at spinal roots and peripheral nerves • Demyelination from macrophages invading basement membrane of Schwann cells

  5. Pathophysiology • Demyelination results in conduction block and flaccid paralysis • Inflammation leads to breakdown of blood-brain barrier • Transudation of plasma proteins into CSF

  6. Prodromal Pathogens • CMV, EBV, other herpesviruses, HIV • Campylobacter jejuni, typhoid, paratyphoid, listeria, Mycoplasma pneumonia • Vaccines • Surgery

  7. Clinical Features • All ages, rare in infants • Three phases: • Progressive • Plateau • Resolution • Miller-Fisher syndrome • Ophthalmoplegia, areflexia, ataxia

  8. Clinical Features • Cranial nerves in 33% (Facial most common) • Sensory disturbance frequent • Pain or paresthesiasof extremeties, back, perioral • Only minimal loss of sensation • Autonomic dysfunction • Tachycardia, bradycardia, HTN, orthostatic hypotension • Rare bowel and bladder dysfunction

  9. Studies • CSF “Cytoalbuminemic disassociation” • Elevated protein • <10 WBC with monocyte predominance • Electrodiagnostic studies aid in dx

  10. Management • ABC’s • Supportive care • Intubation (20%) • CPT • IVIG daily X 5 days • Plasmapheresis equal efficacy • Physical therapy • Steroids not shown to help

  11. Morbidity/Mortality • Causes of death • Autonomic dysfunction • Respiratory failure • 23% residual weakness at least 1 muscle group • Minimal impact on function • Long term weakness associated with • Younger age at onset (<9) • Rapid progression to maximal weakness • May progress to Chronic Inflammatory Demyelinating Neuropathy

More Related